Rifaximin: a new approach to the treatment of travelers' diarrhea. Conclusion.
Ericsson
C D
CD
University of Texas Houston Medical School, Houston, Texas, USA.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003967:Diarrhea / Q000517:prevention & control*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D012294:Rifamycins / Q000627:therapeutic use*; D000078262:Rifaximin; D014195:Travel
D000890:Anti-Infective Agents; D005765:Gastrointestinal Agents; D012294:Rifamycins; D000078262:Rifaximin